Search Results

You are looking at 1 - 1 of 1 items for

  • Author: J. Schrével x
  • Refine by access: All content x
Clear All Modify Search
D. Bermúdez
Search for other papers by D. Bermúdez in
Google Scholar
PubMed
Close
,
D. Escalier
Search for other papers by D. Escalier in
Google Scholar
PubMed
Close
,
J. M. Gallo
Search for other papers by J. M. Gallo in
Google Scholar
PubMed
Close
,
A. Viellefond
Search for other papers by A. Viellefond in
Google Scholar
PubMed
Close
,
F. Ríus
Search for other papers by F. Ríus in
Google Scholar
PubMed
Close
,
I. Pérez de Vargas
Search for other papers by I. Pérez de Vargas in
Google Scholar
PubMed
Close
, and
J. Schrével
Search for other papers by J. Schrével in
Google Scholar
PubMed
Close

A quantitative immunohistochemical study of human spermatogenesis was performed using the 4D4 anti-proacrosin monoclonal antibody (mAb 4D4) as a marker of meiotic and post-meiotic germ cell differentiation. Cells from 15 testicular biopsies with normal spermatogenesis, 18 with slight and nine with marked hypospermatogenesis and six with maturation arrest were assigned to spermatogenic stages according to both nuclear maturation and proacrosin labelling patterns. The results showed that four spermatogenesis steps (mid- and late-pachytene primary spermatocytes, early and late spermatids) have to be separately considered for the classification of a given biopsy. Conversely, data from primary spermatocytes in the metaphase, anaphase and telophase stages and secondary spermatocytes did not show significant differences between biopsies. We conclude that: (1) slight hypospermatogenesis is due only to fewer cells entering meiosis, whereas in marked hypospermatogenesis there is also germ cell loss during the later meiotic steps and spermiogenesis; (2) the sloughing of germ cells from the epithelium could be of pathological significance; and (3) immunodetection with mAb 4D4 improves the assessment of spermatogenesis because it can label a protein expressed as early as meiotic prophase. In addition, mAb 4D4 labels a protein which is a marker of the Golgi complex allowing the detection of disturbances of cytoplasmic events during meiosis or spermiogenesis. Such an analysis is facilitated by mAb 4D4 labelling of paraffin-embedded sections.

Free access